← Browse by Condition
Medical Condition

smoking behaviors

Total Trials
6
Recruiting Now
6
Trial Phases
Phase 2

ClinicalMetric tracks all active clinical trials for smoking behaviors sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — smoking behaviors Clinical Trials

How many clinical trials are currently recruiting for smoking behaviors?
ClinicalMetric currently tracks 6 actively recruiting clinical trials for smoking behaviors, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 6. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for smoking behaviors?
smoking behaviors research spans Phase 2 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a smoking behaviors clinical trial?
Eligibility criteria for smoking behaviors trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2
1
Top Sponsors
Medical University of South Carolina 1 trial
RAI Services Company 1 trial
Georgia State University 1 trial
West Virginia University 1 trial
University of Southern California 1 trial

Recruiting Clinical Trials

NCT06373679
Recruiting
Switch or Quit R01
Enrollment
225 pts
Location
United States
Sponsor
Medical University of South Ca...
View Trial →
NCT07132814
Recruiting
Abuse Liability for Five Modern Oral Nicotine Products
Enrollment
40 pts
Location
United States
Sponsor
RAI Services Company
View Trial →
NCT05000632
Recruiting
Smoke Free SafeCare: Establishing a Smoke Free Home in CPS-involved Families
Enrollment
268 pts
Location
United States
Sponsor
Georgia State University
View Trial →
NCT06228235
Recruiting
rTMS-concurrent Behavioral Priming for Reducing Smoking Cravings
Enrollment
20 pts
Location
United States
Sponsor
West Virginia University
View Trial →
NCT07602699 Phase 2
Recruiting
Multi-Site Trial of Tirzepatide for Smoking Cessation
Enrollment
300 pts
Location
United States
Sponsor
University of Southern Califor...
View Trial →
NCT07459621
Recruiting
Evaluation of a Novel mHealth Intervention for People Who Are Ambivalent About Quitting Smoking
Enrollment
800 pts
Location
United States
Sponsor
Kaiser Permanente
View Trial →

Related Conditions

cigarette smoking (1) smoking (1) tobacco use (1) tobacco smoking (1) child maltreatment (1) smoking reduction (1) smoking cessation (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology